Four ways Biogen is tackling digital innovation in neurological disease
pharmaphorum
DECEMBER 11, 2022
It can mean everything from patient-facing disease management apps and wearables to background AI dramatically altering drug discovery or radiological imaging. About half of our talents come from the life sciences industry and clinical research, and the other half come from the tech world – so, totally different backgrounds,” Hadjiat said. “We
Let's personalize your content